The Scottish Health Industry Partnership (SHIP), part of the Scottish Government Chief Scientist Office (CSO), working with Health Innovation South East Scotland wish to engage with interested suppliers in the marketplace prior to a potential future Pre-Commercial Procurement for Remote Asthma Management.
The Scottish Health Industry Partnership (SHIP), part of the Scottish Government Chief Scientist Office (CSO), working with Health Innovation South East Scotland, wish to engage with interested suppliers in the marketplace prior to a future Small Business Research Initiative (SBRI) to develop disruptive innovative solutions that focus on the Remote Asthma Monitoring for Children.
There is currently the opportunity to respond to a preliminary market consultation on the topic of using innovation to provide Remote Asthma Monitoring for Children. Link to Preliminary Market Consultation Notice.
Please submit questionnaires and any questions regarding the Preliminary Market Consultation through Public Contracts Scotland via the Notice.
Asthma affects approximately 1 in 11 people in the UK. It is one of the few chronic health conditions that affects children and young people more than older people. Asthma is a fluctuating condition with periods of stability and periods of poor control. Predicting poor control is difficult. Overall cost to the NHS is greater than GBP 1 billion per year.
An asthma attack, where there is loss of control, is often on the background of family or life changes and poor adherence. Viral infections, environmental triggers, seasonal changes etc. upset symptom control and lead to an attack. This attack is the end point of a period of loss of symptom control which may be up to a month in development. While adherence to treatment is a major factor influencing risk of attack, there are many other underlying complex issues that prevent children and young people to adhering to their medication.
The Scottish Government Scottish Health and Industry Partnership (SHIP) plan to launching a future Pre-Commercial Procurement (PCP). Our goal is to work with industry partners to develop a fully integrated clinical system that detects which individuals are at risk of an asthma attack and displays this to the relevant clinician who can then offer an intervention to reduce the risk. This could enable education and treatment plans to be focussed and personalised to the individual and could involve more enhanced remote monitoring that passively collects additional data to help understand the symptom burden and adherence pattern.
A further aim of the potential solution is to develop an appointment system that recognises varying preferences amongst young people and is responsive to needs of patients – e.g. appointments can be patient initiated or clinician initiated at short notice. At this stage we would like to invite interested industry parties to take part in this Preliminary Market Consultation by completing a questionnaire to aid our understanding regarding the potential for your organisation to solve the Challenge.
The potential innovative mechanisms and technologies which could be considered, include but are not limited to:
- data analytics
- remote monitoring
- wearable devices or patches
- smartphone apps
- AI and machine learning
- virtual reality and augmented reality
In the long term we wish to develop innovative solutions that see a reduction in the reliance of people with asthma on emergency care services because signs of deterioration are met with a specific and focussed clinical response.
Consultation closes on 3rd August 2023.
Please note: To access the supporting documents including questionnaire, you need to click the button ‘Register your interest now’.
Please note: This notice is for Preliminary Market Consultation for pre-tender supplier engagement only.